Freely Filtered 028: Finerenone for diabetic kidney disease
Freely Filtered, a NephJC Podcast
Diabetic Kidney Disease - Is There a Difference Between the Two?
There was particularly in high BMI patients, an indication that the benefit was less strong in that group. There weren't any other safety outcomes really to report the safety, the adverse events were otherwise balanced between the two groups. We see an 18% spread in their primary outcome, which is 40% drop in E-GFR death by renal cause or E-S-K-D defined as a GFR lesson, 15 or dialysis. And this is despite the fact that they did not enroll anybody who had a potassium greater than 4.8,. They still found a real about 5% of patients, 4% of patients having potassium is greater than 6 at some point during the trial.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
